A multicenter, phase IV observational study of ofatumumab in chronic lymphocytic leukemia (CLL): a European research initiative on CLL (ERIC) study
Autoři
MORENO, C., M. MONTILLO, P. PANAYIOTIDIS, A. BLOOR, J. DUPUIS, A. SCHUH, S. NORIN, C. GEISLER, P. HILLMEN, Michael DOUBEK, Marek TRNĚNÝ, P. OBRTLÍKOVÁ, L. LAURENTI, S. STILGENBAUER, Lukáš SMOLEJ, P. GHIA, F. CYMBALISTA, U. JAEGER, K. STAMATOPOULOS, N. STAVROYIANNI, P. CARRINGTON, H. ZOUABI, V. LEBLOND, GOMEZ GOMEZ JC., R. MARASCA, G. MUSURACA, L. RIGACCI, L. FARINA, R. PAOLINI, Šárka POSPÍŠILOVÁ, E. KIMBY, C. BRADLEY a E. MONTSERRAT
MORENO, C., M. MONTILLO, P. PANAYIOTIDIS, A. BLOOR, J. DUPUIS, A. SCHUH, S. NORIN, C. GEISLER, P. HILLMEN, Michael DOUBEK, Marek TRNĚNÝ, P. OBRTLÍKOVÁ, L. LAURENTI, S. STILGENBAUER, Lukáš SMOLEJ, P. GHIA, F. CYMBALISTA, U. JAEGER, K. STAMATOPOULOS, N. STAVROYIANNI, P. CARRINGTON, H. ZOUABI, V. LEBLOND, GOMEZ GOMEZ JC., R. MARASCA, G. MUSURACA, L. RIGACCI, L. FARINA, R. PAOLINI, Šárka POSPÍŠILOVÁ, E. KIMBY, C. BRADLEY a E. MONTSERRAT. A multicenter, phase IV observational study of ofatumumab in chronic lymphocytic leukemia (CLL): a European research initiative on CLL (ERIC) study. In XV iwCLL, Cologne, Německo. 2013.
@proceedings{1130897, author = {Moreno, C. and Montillo, M. and Panayiotidis, P. and Bloor, A. and Dupuis, J. and Schuh, A. and Norin, S. and Geisler, C. and Hillmen, P. and Doubek, Michael and Trněný, Marek and Obrtlíková, P. and Laurenti, L. and Stilgenbauer, S. and Smolej, Lukáš and Ghia, P. and Cymbalista, F. and Jaeger, U. and Stamatopoulos, K. and Stavroyianni, N. and Carrington, P. and Zouabi, H. and Leblond, V. and Gomez Gomez JC., and Marasca, R. and Musuraca, G. and Rigacci, L. and Farina, L. and Paolini, R. and Pospíšilová, Šárka and Kimby, E. and Bradley, C. and Montserrat, E.}, booktitle = {XV iwCLL, Cologne, Německo}, language = {eng}, title = {A multicenter, phase IV observational study of ofatumumab in chronic lymphocytic leukemia (CLL): a European research initiative on CLL (ERIC) study}, year = {2013} }
TY - CONF ID - 1130897 AU - Moreno, C. - Montillo, M. - Panayiotidis, P. - Bloor, A. - Dupuis, J. - Schuh, A. - Norin, S. - Geisler, C. - Hillmen, P. - Doubek, Michael - Trněný, Marek - Obrtlíková, P. - Laurenti, L. - Stilgenbauer, S. - Smolej, Lukáš - Ghia, P. - Cymbalista, F. - Jaeger, U. - Stamatopoulos, K. - Stavroyianni, N. - Carrington, P. - Zouabi, H. - Leblond, V. - Gomez Gomez JC., AU - Marasca, R. - Musuraca, G. - Rigacci, L. - Farina, L. - Paolini, R. - Pospíšilová, Šárka - Kimby, E. - Bradley, C. - Montserrat, E. PY - 2013 TI - A multicenter, phase IV observational study of ofatumumab in chronic lymphocytic leukemia (CLL): a European research initiative on CLL (ERIC) study ER -
MORENO, C., M. MONTILLO, P. PANAYIOTIDIS, A. BLOOR, J. DUPUIS, A. SCHUH, S. NORIN, C. GEISLER, P. HILLMEN, Michael DOUBEK, Marek TRNĚNÝ, P. OBRTLÍKOVÁ, L. LAURENTI, S. STILGENBAUER, Lukáš SMOLEJ, P. GHIA, F. CYMBALISTA, U. JAEGER, K. STAMATOPOULOS, N. STAVROYIANNI, P. CARRINGTON, H. ZOUABI, V. LEBLOND, GOMEZ GOMEZ JC., R. MARASCA, G. MUSURACA, L. RIGACCI, L. FARINA, R. PAOLINI, Šárka POSPÍŠILOVÁ, E. KIMBY, C. BRADLEY a E. MONTSERRAT. A multicenter, phase IV observational study of ofatumumab in chronic lymphocytic leukemia (CLL): a European research initiative on CLL (ERIC) study. In \textit{XV iwCLL, Cologne, Německo}. 2013.